BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects

NCT05418803 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: YHP1807 Tab. 2.5mg
DRUG: YHR1901 Tab. 2.5mg

Sponsor

Yuhan Corporation